Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity

Diabetes Research and Clinical Practice

Volumn 95, Issue 3, 2012, Pages

  Nakatsuji, Hideaki ^a   Kishida, Ken ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Abdominal obesity; Pioglitazone; S100A8 A9 (MRP8 14) complex; Thiazolidinediones

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CALGRANULIN A; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; PROTEIN S 100; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; STANDING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CALGRANULIN A; CALGRANULIN B; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; THIAZOLIDINEDIONES;

EID: 84857235506     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.11.018     Document Type: Article

References (17)

1. Roper N.A., Bilous R.W., Kelly W.F., Unwin N.C., Connolly V.M. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. Br Med J 2001, 322:1389-1393.
2. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003, 169:203-214. Review.
3. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50:2094-2099.
4. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52:1655-1663.
5. Nakatsuji H., Kishida K., Funahashi T., Shimomura I. Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes. Atherosclerosis 2010, 212:243-245. Senri Study II Group.
6. Staels B. PPARgamma and atherosclerosis. Curr Med Res Opin 2005, 21(Suppl. 1):S13-S20.
7. Ravasi T., Hsu K., Goyette J., Schroder K., Yang Z., Rahimi F., et al. Probing the S100 protein family through genomic and functional analysis. Genomics 2004, 84:10-22.
8. Peng W.H., Jian W.X., Li H.L., Hou L., Wei Y.D., Li W.M., et al. Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients. Cardiovasc Diabetol 2011, 10:41.
9. Hiuge-Shimizu A., Maeda N., Hirata A., Nakatsuji H., Nakamura K., Okuno A., et al. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone. Arterioscler Thromb Vasc Biol 2011, 31:792-799.
10. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992.
11. Kishida K., Funahashi T., Matsuzawa Y., Shimomura I. Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med 2011, (May).
12. Croce K., Gao H., Wang Y., Mooroka T., Sakuma M., Shi C., et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009, 120:427-436.
13. Bouzidi F., Doussiere J. Binding of arachidonic acid to myeloid-related proteins (S100A8/A9) enhances phagocytic NADPH oxidase activation. Biochem Biophys Res Commun 2004, 325:1060-1065.
14. Kerkhoff C., Nacken W., Benedyk M., Dagher M.C., Sopalla C., Doussiere J. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J 2005, 19:467-469.
15. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007, 13:1042-1049.
16. Boyd J.H., Kan B., Roberts H., Wang Y., Walley K.R. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 2008, 102:1239-1246.
17. Lagasse E., Clerc R.G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol 1988, 8:2402-2410.